Tenofovir disoproxil fumarate

Tenofovir disoproxil fumarate Reactions 1680, p320 - 2 Dec 2017 Kidney dysfunction: 5 case reports In a retrospective cohort study, 5 men aged between 40 75 years were described, who developed kidney dysfunction during treatment with tenofovir disoproxil fumarate for HIV-1-infection [dosages, routes and time to reactions onsets not stated]. Patient 1: A 40-year-old man developed kidney dysfunction with creatinine level increased from 0.9 mg/dL to 1.6 mg/dL and estimated glomerular filtration rate (eGFR) decreased from 2 2 106 mL/min/1.73m to 53 mL/min/1.73m . He received tenofovir disoproxil fumarate for 663 days, along with lamivudine and lopinavir/ritonavir. His creatinine level decreased to 1.3 mg/dL and eGFR increased to 67 mL/min/1.73m after the discontinuation of the tenofovir disoproxil fumarate therapy. Patient 2: A 43-year-old man developed kidney dysfunction with creatinine level increased from 1.5 mg/dL to 1.9 mg/dL and eGFR decreased from 53 mL/min/1.73m2 to 42 mL/min/1.73m . He received tenofovir disoproxil fumarate for 869 days, along with lamivudine and efavirenz. His creatinine level decreased to 1.5 mg/dL and eGFR increased to 55 mL/min/1.73m after the discontinuation of the tenofovir disoproxil fumarate therapy. Patient 3: A 50-year-old man developed kidney dysfunction with creatinine level increased from 1.2 mg/dL to 1.8 mg/dL and eGFR decreased from 70 mL/min/1.73m to 42 mL/min/1.73m . He received tenofovir disoproxil fumarate for 530 days, days, along with lamivudine and nevirapine. His creatinine level decreased to 1.7 mg/dL and eGFR increased to 45 mL/min/1.73m after the discontinuation of the tenofovir disoproxil fumarate therapy. Patient 4: A 54-year-old man developed kidney dysfunction with creatinine level increased from 1.1 mg/dL to 1.9 mg/dL and eGFR decreased from 76 mL/min/1.73m to 39 mL/min/1.73m . He received tenofovir disoproxil fumarate for 311 days, days, along with lamivudine and raltegravir. His creatinine level decreased to 1.8 mg/dL and eGFR increased to 41 mL/min/1.73m after the discontinuation of the tenofovir disoproxil fumarate therapy. Patient 5: A 75-year-old man developed kidney dysfunction with creatinine level increased from 1.1 mg/dL to 1.9 mg/dL and eGFR decreased from 65 mL/min/1.73m to 33 mL/min/1.73m . He received tenofovir disoproxil fumarate for 738 days, along with lamivudine and lopinavir/ritonavir. His creatinine level increased to 2.2 mg/dL and eGFR decreased to 28 mL/min/1.73m after the discontinuation of the tenofovir disoproxil fumarate therapy. Author comment: "Five (1.3%) patients withdrew [tenofovir disoproxil fumarate] due to increased serum creatinine levels during the study period." Huang Y-S, et al. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients. Journal of Microbiology, Immunology and Infection 50: 595-603, No. 5, Oct 2017. Available from: URL: http://doi.org/10.1016/j.jmii.2015.08.019 - Taiwan 803285127 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Tenofovir disoproxil fumarate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/tenofovir-disoproxil-fumarate-HUWNztAvdU
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39251-2
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial